Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Campaign success as new NHS England programme launches to get medication delivered on time in hospital Date 27 September 2024 Following years of relentless campaigning by our community and charity, NHS England has committed to ensuring that time critical medication is delivered on time in hospitals as part of an exciting 3-year Medicines Safety Improvement Programme.
Pioneering Landmark project launches Date 23 September 2024 Parkinson’s UK led consortium is using big data to accelerate new treatment options, aiming to unlock a cure for Parkinson’s.
We're investing in the Beech Band, a wearable device that aims to manage Parkinson's symptoms Date 20 September 2024 The Beech Band, designed by Carl Beech, is a wearable device showing promising signs of being able to manage symptoms including speech issues, anxiety and gait.
Lord Darzi's report reveals urgent need to fix the NHS Date 18 September 2024 On 12 September, Lord Darzi released his report on the state of the NHS in England, based on his independent investigation. It highlights many challenges for people with Parkinson's.
Nominate your Parkinson's hero for a Community Award Date 17 September 2024 The Community Awards are back for a second year. Nominate your unsung hero from the Parkinson's community.
Caption Holyrood, Scottish Parliament Scottish government to take forward our research participation proposals Date 6 September 2024 Measures in the Scottish government’s programme will affect the Parkinson’s community in many ways. One important new law will enable more people with Parkinson’s to take part in vital research.
Parkinson's medication: supply update Date 5 September 2024 Here are the latest medication supply issues we are aware of.
Lewy body dementia diagnosis data revealed for the first time Date 2 September 2024 Parkinson's UK welcomes the first release of Lewy body dementia diagnosis data.
Progress towards a form of adaptable deep brain stimulation Date 19 August 2024 A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
Parkinson's UK invests in developing potential new drug with Acurex Biosciences Date 7 August 2024 We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
